The COVID-19 vaccination status, age, monocyte percentage, prothrombin activity, cardiac troponin T, and total bilirubin (“VAMPCT”) were the most relevant factors and utilized to develop the scoring system with an AUC of 0.960 (95% CI 0.935, 0.985). This evidence concerns the gene F2 and COVID-19.